Maxigen Biotech Inc. (1783.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.84B |
| Enterprise Value | 3.36B |
| P/E Ratio | 12.72 |
| PEG Ratio | 0.43 |
| Price/Sales Ratio | 4.19 |
| Price/Book Ratio | 2.12 |
| Enterprise/Revenue | 3.52 |
| Enterprise/EBITDA | 9.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.33 |
| Operating Margin | 0.32 |
AD
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.18 |
Income Statement
| Revenue | 811.56M |
| Revenue/Share | 9.22 |
| Gross Profit | 563.72M |
| EBITDA | 293.18M |
| Net Income | 265.31M |
| Diluted EPS | 2.96 |
Balance Sheet
| Total Cash | 951.03M |
| Total Cash/Share | 10.63 |
| Total Debt | 100.5M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 3.32 |
| Book Value Per Share | 18.18 |
Price History
| 52-Week Change | -11.38 |
| 52-Week High | 48.85 |
| 52-Week Low | 37.8 |
| Moving Average 50 Days | 39.55 |
| Moving Average 200 Days | 42.89 |
Statistics
| Average Volume | 116,117 |
| Shares Outstanding | 89.68M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.83 |
| Trailing Annual Dividend Yield | 2.15 |
| Payout Ratio | 0.27 |
| Last Split Factor | 21:20 |
| Last Split Date | September 07, 2023 |
AD
